F Dx Advisors, Inc. Pacific Biosciences Of California, Inc. Transaction History

F Dx Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$5.97 - $10.36 $4,865 - $8,443	815 Added 4.44%	19,181 $188,000
Q3 2023 Nov 02, 2023	BUY	$8.23 - $13.93 $36,030 - $60,985	4,378 Added 31.3%	18,366 $153,000
Q2 2023 Jul 17, 2023	BUY	$9.97 - $14.05 $17,278 - $24,348	1,733 Added 14.14%	13,988 $186,000
Q4 2022 Feb 09, 2023	BUY	$5.67 - $11.2 $6,673 - $13,182	1,177 Added 10.62%	12,255 $100,000
Q3 2022 Nov 10, 2022	SELL	$3.93 - $8.57 $2,959 - $6,453	-753 Reduced 6.36%	11,078 $64,000
Q2 2022 Aug 03, 2022	SELL	$4.02 - $10.43 $3,939 - $10,221	-980 Reduced 7.65%	11,831 $52,000
Q1 2022 May 03, 2022	BUY	$8.43 - $20.9 $107,996 - $267,749	12,811 New	12,811 $117,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.